Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Tenders 2009 > News item |
CV Therapeutics retired more than $100 million of convertibles in 2008
By Jennifer Chiou
New York, Jan. 16 - CV Therapeutics Inc. retired more than $100 million of its convertible debt securities in the fiscal year ended Dec. 31 through repurchases and exchanges, according to an 8-K filing with the Securities and Exchange Commission.
CV Therapeutics is a biopharmaceutical company based in Palo Alto, Calif.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.